Business Description
![Kura Oncology Inc Kura Oncology Inc logo](https://static.gurufocus.com/logos/0C0000AZHG.png?14)
Kura Oncology Inc
NAICS : 325414
SIC : 2836
ISIN : US50127T1097
Description
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 31.06 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -7 | |||||
3-Year EPS without NRI Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | -7.9 | |||||
3-Year Book Growth Rate | -16.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.29 | |||||
9-Day RSI | 47.01 | |||||
14-Day RSI | 47.61 | |||||
6-1 Month Momentum % | 50.17 | |||||
12-1 Month Momentum % | 108.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.67 | |||||
Quick Ratio | 16.67 | |||||
Cash Ratio | 16.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -15.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -38.43 | |||||
ROA % | -35.06 | |||||
ROIC % | -802.72 | |||||
ROC (Joel Greenblatt) % | -2217.45 | |||||
ROCE % | -36.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.11 | |||||
Price-to-Tangible-Book | 3.11 | |||||
EV-to-EBIT | -6.36 | |||||
EV-to-Forward-EBIT | -4.75 | |||||
EV-to-EBITDA | -6.39 | |||||
EV-to-Forward-EBITDA | -4.75 | |||||
EV-to-Forward-Revenue | 10.12 | |||||
EV-to-FCF | -7.67 | |||||
Price-to-Net-Current-Asset-Value | 3.21 | |||||
Price-to-Net-Cash | 3.28 | |||||
Earnings Yield (Greenblatt) % | -15.72 | |||||
FCF Yield % | -8.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KURA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kura Oncology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.17 | ||
Beta | 0.26 | ||
Volatility % | 64.82 | ||
14-Day RSI | 47.61 | ||
14-Day ATR ($) | 0.886975 | ||
20-Day SMA ($) | 20.94 | ||
12-1 Month Momentum % | 108.64 | ||
52-Week Range ($) | 7.41 - 24.17 | ||
Shares Outstanding (Mil) | 76.18 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kura Oncology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kura Oncology Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kura Oncology Inc Frequently Asked Questions
What is Kura Oncology Inc(KURA)'s stock price today?
The current price of KURA is $20.60. The 52 week high of KURA is $24.17 and 52 week low is $7.41.
When is next earnings date of Kura Oncology Inc(KURA)?
The next earnings date of Kura Oncology Inc(KURA) is 2024-08-02 Est..
Does Kura Oncology Inc(KURA) pay dividends? If so, how much?
Kura Oncology Inc(KURA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |